Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota.
- 2018-02-05
- Clinical Trial
- Food & Function 7(9)
- Peijun Tian
- Baolong Li
- Canxia He
- Wei Song
- Aiju Hou
- Sicong Tian
- Xinyu Meng
- Kaikai Li
- Yujuan Shan
- PubMed: 27713957
- DOI: 10.1039/C6FO00831C
12 Insights on
- Improved Intestinal Barrier Function
- Reduced Intestinal Permeability
- Reduced Inflammation Levels
- Improved Glucose Tolerance
- Improved Immunomodulation
- Reduced Pro-inflammatory Cytokine Levels
- Enhanced Immune Function
- Improved Epithelial Barrier Function
- Reduced Blood HbA1c Levels
- Reduced IL-6 Levels
- Reversed Thymic Atrophy
- Reduced Islet β-Cell Dysfunction
- Low evidence
- Highly Cited
- Animal Study